Accent Capital Management, LLC
Position in TERN — Terns Pharmaceuticals, Inc.
CIK 2014179
CENTERVILLE, OH
Position in TERN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$9,911
+$4,861 QoQ
Shares Held
188
+50.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#284
of 316 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Accent Capital Management, LLC holds $294,025 across 17 Biotechnology names. TERN ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
167 | $121,951 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
70 | $36,642 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
347 | $32,055 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
310 | $25,819 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
50 | $16,109 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
This page
|
188 | $9,911 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
568 | $8,804 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
230 | $8,767 |
All Filings in TERN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,911 | 188 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,050 | 125 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||